CClinicalTrials.gg
CompletedNCT06551935Updated Mar 10, 2025

Effect of Sleep Hygiene and Sleep Extension on Performance in Soccer Players

An interventional study of Habitual sleep habits without intervention and Sleep extension and sleep hygiene in Sleep Extension, Sleep Hygiene and Athletic Performance, sponsored by University of Maia. Completed at 1 site in Portugal. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-10.

Sponsored by University of Maia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

Sleep is essential for recovery and performance in athletes, yet they often struggle with inadequate sleep duration and quality. Theoretically, strategies such as sleep extension and sleep hygiene could improve sleep and subsequent recovery in athletes, but their effectiveness remains largely unstudied in the literature. This study aimed to analyze the effects of sleep extension and sleep hygiene on physical and cognitive performance in soccer players.

Read the detailed description

Twenty soccer players will be randomized (1:1 ratio) into intervention and control groups. The study will last 4 weeks, divided into two periods: baseline (2 weeks) and intervention (2 weeks). In the baseline period, the players will maintain their normal routine and their sleep habits will be monitored by actigraphy and sleep diaries. The players physical performance will be assessed by the 30-15 intermittent fitness test, countermovement jump, isometric mid-thigh pull and 30-meter sprint, while the cognitive performance will be assessed with the 3-minute psychomotor vigilance test. During the intervention period, the intervention group will extend their usual time in bed by 25% than their baseline period, and adopt sleep hygiene behaviors, while the control group will maintain their usual sleep routine. The physical performance of the players of both groups will be assessed with the same physical tests of the baseline period at the end of week 1 and week 2.

02

Conditions studied

  • Sleep Extension
  • Sleep Hygiene
  • Athletic Performance
03

In context

Lead sponsor

University of Maia is the lead sponsor of 21 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age: ≥18 years old
  • Sex: Male
  • Football players competed in an official competition, organized by the Portuguese Football - Federation (FPF) or regional football associations

Exclusion criteria

Exclusion Criteria:

  • Players who take sleep medication
  • Injured players
  • Players with clinical sleep problems
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • Active comparator
    Control Group

    Without sleep intervention

    Behavioral: Habitual sleep habits without intervention

  • Experimental
    Experimental Group

    Sleep hygiene and sleep extension

    Behavioral: Sleep extension and sleep hygiene

Interventions

  • BehavioralHabitual sleep habits without intervention

    Sleep habits maintenance

  • BehavioralSleep extension and sleep hygiene

    Players will extend their time in bed by 25%, based on their baseline sleep, and adopt sleep hygiene behaviors: relatively fixed sleep schedule; do not lie in bed awake for long periods of time; no caffeine and no alcohol prior to bedtime; avoid heavy meals close to bedtime; sleep environment cool, dark and quiet; low exposure to screen lights before bedtime, only with nightshift mode and low luminosity (avoid high cognitive demanded activities, like gaming); low luminosity near to bedtime; ensure adequate exposure to light in the morning.

06

What researchers measure

Primary outcomes

  1. Sleep

    Night-time sleep will be monitored each night during the data collection period using wrist-worn actigraphy devices (Actigraph LLC wGT3X-BT, Pensacola, USA). Data will be analyzed using company software (ActiLife LLC Pro software v6.13.3, Pensacola, USA). The sampling frequency will be set to 50 Hz, and the epoch of activity counts 60 s. All sleep variables will be determined using the Sadeh's algorithm

    Time frame: 4 weeks

  2. 30-15 Intermittent Fitness Test

    The 30-15 IFT consists of 30-second shuttle runs interspersed with 15-second periods of passive recovery. The initial running speed is set at 8 km/h for the first 30-second run and increased by 0.5 km/h for each subsequent stage. Participants ran back and forth between 2 lines 40 m apart at a pace dictated by a pre-recorded beep. During the 15-s recovery period, each player walked forward to the nearest of the 3 lines (in the middle or at one end of the running area, depending on where the previous leg was completed) in preparation for the next leg. Players were instructed to complete as many legs as possible, and the test ended when a player could no longer maintain the prescribed running speed or was unable to reach a 3-m zone around each line at the time of the audio signal on 3 consecutive occasions. If a player was unable to complete the stage, their score was recorded as the last stage they successfully completed, and their running speed was recorded as their VIFT.

    Time frame: At the end of the baseline period (2 weeks), after one week of sleep extension and sleep hygiene (intervention period) and after two weeks of sleep extension and sleep hygiene (intervention period)

Secondary outcomes

  1. 30-meters sprint test

    The sprint time (seconds) for 15 and 30 m will be recorded using a photocell system (WITTY, Microgate, Bolzano, Italy). Three photocells will be used to assess 15 and 30 m so that both times could be recorded in a single attempt. Subjects will be asked to assume a stationary starting position with the front foot placed 50 cm behind the first cell. Two maximal attempts will be allowed for all tests, with the best result recorded for analysis.

    Time frame: At the end of the baseline period (2 weeks), after one week of sleep extension and sleep hygiene (intervention period) and after two weeks of sleep extension and sleep hygiene (intervention period)

  2. Countermovement jump (CMJ)

    The CMJ will be recorded with optical detection system (Optogait, Microgate, Bolzano, Italy) and performed with the hands placed on the hips, maintaining the extension of the hip, knee and ankle joints during airtime. Depth during countermovement will be standardized for all players and the average height of three attempts will be recorded.

    Time frame: At the end of the baseline period (2 weeks), after one week of sleep extension and sleep hygiene (intervention period) and after two weeks of sleep extension and sleep hygiene (intervention period)

  3. Isometric Mid-thigh pull (IMTP)

    The IMTP will be performed using a force platform (ForceDecks, VALD, Brisbane, Australia). Athletes will adopt a standard power-pulling stance, with the bar height set to half the thigh length (50% of the distance between the greater trochanter and lateral epicondyle of the knee). Knee and hip angles will be set to 130-140°. Athletes will perform the IMTP two times at maximal effort. Athletes will be instructed to pull upward on the bar "as quickly and explosively as possible," maintaining maximal effort for two to three seconds.

    Time frame: At the end of the baseline period (2 weeks), after one week of sleep extension and sleep hygiene (intervention period) and after two weeks of sleep extension and sleep hygiene (intervention period)

  4. 3-min Psychomotor Vigilance Test (PVT)

    The PVT is a standard task used to measure reaction time and has been shown to be sensitive to sleep restriction. The PVT is a 3-minute, iPad-based task (Joggle Research software) requiring athletes to concentrate on a red rectangular box on the screen and tap the screen when a yellow timer appeared in the center of the box. The timer stopped once the participant had responded, indicating the response time in milliseconds. The interstimulus interval varied randomly from 1 to 4 seconds. Responses ≤100ms were labeled "false starts" and responses ≥355 ms were labeled "lapses."

    Time frame: At the end of the baseline period (2 weeks), after one week of sleep extension and sleep hygiene (intervention period) and after two weeks of sleep extension and sleep hygiene (intervention period)

07

Study locations

1 site
  • University of Maia
    Maia, Porto, Portugal
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06551935
Lead sponsor
University of Maia
Responsible party
Lúcio Cunha (Principal Investigator, University of Maia) — Principal investigator
First posted
Aug 13, 2024
Start date
Aug 20, 2024
Primary completion
Sep 20, 2024
Completion
Feb 6, 2025
Last update
Mar 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion